Literature DB >> 2958885

The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory.

J C Winter1, D T Petti.   

Abstract

A group of ten rats was trained to obtain food pellets in an 8-arm radial maze. The effects of pretreatment with (+)-Lysergic acid diethylamide (+)-tartrate (LSD), m-trifluoromethylphenylpiperazine (TFMPP), 5-methoxy-N,N-dimethyltryptamine oxalate (5-MeO-DMT), racemic 8-hydroxy-2-(di-n-propylamino)tetralin HBr (8-OH-DPAT), and 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole succinate (RU 24969) were then evaluated. All drugs were administered IP 15 min before testing. With the exception of an increased rate of responding at a dose of 0.1 mg/kg of 8-OH-DPAT, all drugs produced a dose-related decline in response rate. In addition, LSD, RU 24969, and 8-OH-DPAT caused a statistically significant decrease in efficiency of responding. Of the three, 8-OH-DPAT was clearly the most active. Doses of 0.3, 1.0, and 3.0 mg/kg resulted in efficiencies of 61%, 53%, and 44%, respectively. The present results taken in light of 8-OH-DPAT's preferential binding to 5-HT1A receptors, the high density of these receptors in hippocampus, and the observation that the number of 5-HT1A receptors is decreased in Alzheimer's disease, suggest a possible role for this serotonergic receptor subtype in memory.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958885     DOI: 10.1016/0091-3057(87)90184-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  12 in total

1.  Hippocampal 5-hydroxytryptamine synthesis is greater in female rats than in males and more decreased by the 5-HT1A agonist 8-OH-DPAT.

Authors:  D J Haleem; G A Kennett; G Curzon
Journal:  J Neural Transm Gen Sect       Date:  1990

2.  Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists.

Authors:  K J Stanhope; A P McLenachan; C T Dourish
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

3.  The 5-HT1A receptor and the stimulus effects of LSD in the rat.

Authors:  C J Reissig; J R Eckler; R A Rabin; J C Winter
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 4.  Serotonin, memory, and the aging brain.

Authors:  W J McEntee; T H Crook
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  8-Hydroxy-2-(di-n-propylamino)tetralin impairs spatial learning in a water maze: role of postsynaptic 5-HT1A receptors.

Authors:  M Carli; R Samanin
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

6.  Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior.

Authors:  M Riekkinen; J Sirviö; T Toivanen; P Riekkinen
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

7.  Intraseptal injection of the 5-HT1A/5-HT7 agonist 8-OH-DPAT and working memory in rats.

Authors:  Hélène Jeltsch; Fabrice Bertrand; Rodrigue Galani; Christine Lazarus; Sarah Schimchowitsch; Jean-Christophe Cassel
Journal:  Psychopharmacology (Berl)       Date:  2004-03-11       Impact factor: 4.530

8.  The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component.

Authors:  C J Reissig; J R Eckler; R A Rabin; K C Rice; J C Winter
Journal:  Pharmacol Biochem Behav       Date:  2007-09-19       Impact factor: 3.533

9.  5-HT1A receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task.

Authors:  B J Cole; G H Jones; J D Turner
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

Review 10.  [Relations between specific neurochemical systems and memory: problems posed by dementia of the Alzheimer type].

Authors:  I Lussier; E Stip
Journal:  J Psychiatry Neurosci       Date:  1995-01       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.